Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Potent In Vivo Anti-Tumor Activity Of Extracellular Vesicles Isolated From Genetically Engineered Primary Mesenchymal Stromal Cells Expressing The Trans-Membrane TNF-Related Apoptosis-Inducing Ligand (TRAIL)

Stefano Buttiglieri, PhD, Carmelo Carlo-Stella, MD, Tiziana Spatola, BiolSc, Roberta Pulito, BiolSc, Luigi Naldini, MD, PhD, Andrea Anichini, PhD, Michele Magni, MD, Arianna Giacomini, PhD, Corrado Tarella, MD, Alessandro M. Gianni, MD

Blood (2013) 122 (21): 1658.

https://doi.org/10.1182/blood.V122.21.1658.1658

Published: 2013

Journal Articles

Early and Permanent Telomere Shortening in Bone Marrow-Derived Cells Following Chemotherapy: A Parallel Study In Vivo in Lymphoma Patients and In Vitro in Cultured Mesenchymal Stem Cells

Angela Gueli, MD, Marco Ruella, MD, Alessandra Risso, PhD, Tiziana Spatola, PhD, Hui Jing Hu, MD, Daniela Gottardi, MD, Alberto De Crescenzo, MD, Stefano Buttiglieri, PhD, Corrado Tarella, MD

Blood (2011) 118 (21): 1620.

https://doi.org/10.1182/blood.V118.21.1620.1620

Published: 2011

Journal Articles

Exposure of Cultured Human Mesenchymal Stem Cells to Chemotherapy Induces An Early and Permanent Telomere Loss: Biological and Clinical Implications

Stefano Buttiglieri, PhD, Tiziana Spatola, PhD, Marco Ruella, MD, Alessandra Risso, PhD, Melissa Montanini, PhD, Silvia Tracchi, PhD, Lorenzo Silengo, MD, Enrico Avvedimanto, MD, Corrado Tarella, MD

Blood (2010) 116 (21): 4776.

https://doi.org/10.1182/blood.V116.21.4776.4776

Published: 2010

Journal Articles

The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia Following High-Dose Yttrium-90 Ibritumomab Tiuxetan Is Analogous to That Observed Following High-Dose Chemotherapy: a Matched-Pair Analysis In Non-Hodgkin Lymphoma Patients.

Anna Guidetti, MD, Carmelo Carlo-Stella, MD, Marco Ruella, MD, Rosalba Miceli, MD, Liliana Devizzi, MD, Daniela Sia, PhD, Silvia Locatelli, PhD, Arianna Giacomini, PhD, Michele Magni, MD, Paola Matteucci, MD, Stefano Buttiglieri, PhD, Alessandra Risso, PhD, Luigi Mariani, MD, Roberto Passera, PhD, Massimo Di Nicola, MD, Corrado Tarella, MD, Alessandro M. Gianni, MD

Blood (2010) 116 (21): 1289.

https://doi.org/10.1182/blood.V116.21.1289.1289

Published: 2010

Journal Articles

PAX2 expression by HHV-8–infected endothelial cells induced a proangiogenic and proinvasive phenotype

Valentina Fonsato, Stefano Buttiglieri, Maria Chiara Deregibus, Benedetta Bussolati, Elisabetta Caselli, Dario Di Luca, Giovanni Camussi

Blood (2008) 111 (5): 2806–2815.

https://doi.org/10.1182/blood-2007-04-085555

Published: 2008

Journal Articles

Bone Marrow Stroma-Derived Prolactin Is Involved in Basal and Platelet-Activating Factor–Stimulated In Vitro Erythropoiesis

Graziella Bellone, Paola Astarita, Elisa Artusio, Stefania Silvestri, Katia Mareschi, Anna Turletti, Stefano Buttiglieri, Giorgio Emanuelli, Lina Matera

Blood (1997) 90 (1): 21–27.

https://doi.org/10.1182/blood.V90.1.21

Published: 1997

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Potent In Vivo Anti-Tumor Activity Of Extracellular Vesicles Isolated From Genetically Engineered Primary Mesenchymal Stromal Cells Expressing The Trans-Membrane TNF-Related Apoptosis-Inducing Ligand (TRAIL)

Early and Permanent Telomere Shortening in Bone Marrow-Derived Cells Following Chemotherapy: A Parallel Study In Vivo in Lymphoma Patients and In Vitro in Cultured Mesenchymal Stem Cells

Exposure of Cultured Human Mesenchymal Stem Cells to Chemotherapy Induces An Early and Permanent Telomere Loss: Biological and Clinical Implications

The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia Following High-Dose Yttrium-90 Ibritumomab Tiuxetan Is Analogous to That Observed Following High-Dose Chemotherapy: a Matched-Pair Analysis In Non-Hodgkin Lymphoma Patients.

PAX2 expression by HHV-8–infected endothelial cells induced a proangiogenic and proinvasive phenotype

Bone Marrow Stroma-Derived Prolactin Is Involved in Basal and Platelet-Activating Factor–Stimulated In Vitro Erythropoiesis

Email alerts

ASH Publications

American Society of Hematology

Update search

Potent In Vivo Anti-Tumor Activity Of Extracellular Vesicles Isolated From Genetically Engineered Primary Mesenchymal Stromal Cells Expressing The Trans-Membrane TNF-Related Apoptosis-Inducing Ligand (TRAIL)

Early and Permanent Telomere Shortening in Bone Marrow-Derived Cells Following Chemotherapy: A Parallel Study In Vivo in Lymphoma Patients and In Vitro in Cultured Mesenchymal Stem Cells

Exposure of Cultured Human Mesenchymal Stem Cells to Chemotherapy Induces An Early and Permanent Telomere Loss: Biological and Clinical Implications

The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia Following High-Dose Yttrium-90 Ibritumomab Tiuxetan Is Analogous to That Observed Following High-Dose Chemotherapy: a Matched-Pair Analysis In Non-Hodgkin Lymphoma Patients.

PAX2 expression by HHV-8–infected endothelial cells induced a proangiogenic and proinvasive phenotype

Bone Marrow Stroma-Derived Prolactin Is Involved in Basal and Platelet-Activating Factor–Stimulated In Vitro Erythropoiesis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only